Through blood and other biological samples, ISB scientists have shown they can identify markers for cancer years before diagnosis. This was the topic of a recent Research Roundtable presentation delivered by Dr. Andrew Magis, Director of Data Science in ISB’s Health Data Science Lab. Prior to his current role at ISB, Magis was the Director of Research at Arivale, a…
Read More
BBI Faculty Conversations was joined by BBI member Dr. Taran Gujral, Assistant Professor in the Human Biology Division at the Fred Hutchinson Cancer Research Center.   BBI:  To start, could you tell us a little bit about your background and the focus of your work? Dr. Gujral: I had a very broad education and training in mathematics, cell biology, biochemistry, and…
Read More

Faculty Spotlight: Dr. Katherine Bennett

As part of Healthy Aging Month, UW’s faculty spotlight for September is Dr. Katherine Bennett, assistant professor in the Division of Gerontology and Geriatric Medicine. Originally from Cleveland, Ohio, Bennett graduated medical school from the Ohio State University College of Medicine & Public Health and has been a member of the UW Department of Medicine since her Internal Medicine Residency…
Read More
As Prostate Cancer Awareness Month comes to a close, researchers want to circulate the message that some gene mutations linked to breast and ovarian cancer are also associated with prostate cancer. Both sexes have the same risk for inherited gene mutations, such as BRCA1/2 and PALB2, and the same chances of passing the mutation to their children. Yet women were 10 times…
Read More
Astellas Pharma Inc. and Seagen Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PADCEV®(enfortumab vedotin) for radically unresectable urothelial carcinoma that has progressed after anti-cancer chemotherapy. The New Drug Application received priority review. Radically unresectable urothelial carcinoma is urothelial cancer that cannot be treated by surgical removal of the urinary bladder or the kidney and…
Read More
One of your key points was that the “missense variants of unknown significance (VUS) represent a large and growing problem.” Why is this and how does your answer relate to the “bold prediction” of the seminar, “The clinical relevance of all encountered genomics will be readily predicable, rendering the diagnostic designation VUS obsolete? VUS are a large and growing problem…
Read More
After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The company on Tuesday will cut the ribbon on its new 100,086 square-foot headquarters in Seattle’s South Lake Union neighborhood, with Gov. Jay Inslee the keynote speaker. The building, at the site of a former gym and smoothie shop near Fred Hutchinson Cancer Research Center, approximately doubles the…
Read More
For decades, high school teachers used Gregor Mendel and his pea plants to teach kids in ninth grade on up the fundamentals of genetics. Today’s kids don’t care beans about those peas. They want to understand what the science is behind race, racism and genetics. And their teachers are desperate to figure out how to teach this complex topic without…
Read More